These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28891457)

  • 1. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review.
    Hofstraat SHI; Falla AM; Duffell EF; Hahné SJM; Amato-Gauci AJ; Veldhuijzen IK; Tavoschi L
    Epidemiol Infect; 2017 Oct; 145(14):2873-2885. PubMed ID: 28891457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.
    Falla AM; Ahmad AA; Duffell E; Noori T; Veldhuijzen IK
    BMC Infect Dis; 2018 Jan; 18(1):42. PubMed ID: 29338702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update.
    Han R; Zhou J; François C; Toumi M
    BMC Infect Dis; 2019 Jul; 19(1):655. PubMed ID: 31337339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review.
    Bivegete S; McNaughton AL; Trickey A; Thornton Z; Scanlan B; Lim AG; Nerlander L; Fraser H; Walker JG; Hickman M; Vickerman P; Johnson H; Duffell E; Brooks-Pollock E; Christensen H
    Euro Surveill; 2023 Jul; 28(30):. PubMed ID: 37498533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area.
    Tavoschi L; Mason L; Petriti U; Bunge E; Veldhuijzen I; Duffell E
    J Hosp Infect; 2019 Aug; 102(4):359-368. PubMed ID: 30885816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study.
    Trickey A; Bivegete S; Duffell E; McNaughton AL; Nerlander L; Walker JG; Fraser H; Hickman M; Vickerman P; Brooks-Pollock E; Christensen H
    BMC Infect Dis; 2023 Jul; 23(1):457. PubMed ID: 37430220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
    Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
    BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review.
    Mason LM; Duffell E; Veldhuijzen IK; Petriti U; Bunge EM; Tavoschi L
    Euro Surveill; 2019 Jul; 24(30):. PubMed ID: 31362808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
    Aspinall EJ; Hutchinson SJ; Goldberg DJ; Valerio H; Mozalevskis A; Noori T; Duffell E; Tavoschi L
    HIV Med; 2018 Feb; 19 Suppl 1():11-15. PubMed ID: 29488708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA - descriptive analysis and estimation of 2015 baseline.
    Mårdh O; Quinten C; Amato-Gauci AJ; Duffell E
    Infect Dis (Lond); 2020 Sep; 52(9):625-637. PubMed ID: 32644030
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of and risk factors for hepatitis B and C infection among Mongolian blood donors.
    Tserenpuntsag B; Nelson K; Lamjav O; Triner W; Smith P; Kacica M; McNutt LA
    Transfusion; 2010 Jan; 50(1):92-9. PubMed ID: 19788639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.
    Papa A; Felice C; Marzo M; Andrisani G; Armuzzi A; Covino M; Mocci G; Pugliese D; De Vitis I; Gasbarrini A; Rapaccini GL; Guidi L
    J Crohns Colitis; 2013 Mar; 7(2):113-9. PubMed ID: 22464811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance and epidemiology of hepatitis B and C in Europe - a review.
    Rantala M; van de Laar MJ
    Euro Surveill; 2008 May; 13(21):. PubMed ID: 18761967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare-associated hepatitis B and C transmission to patients in the EU/EEA and UK: a systematic review of reported outbreaks between 2006 and 2021.
    Singh J; Stoitsova S; Zakrzewska K; Henszel L; Rosińska M; Duffell E
    BMC Public Health; 2022 Dec; 22(1):2260. PubMed ID: 36463162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hepatitis B and C infections in the Netherlands: estimated prevalence in risk groups and the general population.
    Koopsen J; van Steenbergen JE; Richardus JH; Prins M; Op de Coul ELM; Croes EA; Heil J; Zuure FR; Veldhuijzen IK
    Epidemiol Infect; 2019 Jan; 147():e147. PubMed ID: 30869044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
    Hahné SJ; Veldhuijzen IK; Wiessing L; Lim TA; Salminen M; Laar Mv
    BMC Infect Dis; 2013 Apr; 13():181. PubMed ID: 23597411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review.
    Carrillo-Santisteve P; Tavoschi L; Severi E; Bonfigli S; Edelstein M; Byström E; Lopalco P;
    Lancet Infect Dis; 2017 Oct; 17(10):e306-e319. PubMed ID: 28645862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population.
    Hoffmann G; Berglund G; Elmståhl S; Eriksson S; Verbaan H; Widell A; Lindgren S
    Scand J Gastroenterol; 2000 Aug; 35(8):861-5. PubMed ID: 10994626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis.
    Agyeman AA; Ofori-Asenso R; Mprah A; Ashiagbor G
    BMC Infect Dis; 2016 Aug; 16():391. PubMed ID: 27507267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.